UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049959
Receipt number R000056899
Scientific Title Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-Analysis
Date of disclosure of the study information 2023/01/04
Last modified on 2025/01/05 12:25:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-Analysis

Acronym

Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia

Scientific Title

Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-Analysis

Scientific Title:Acronym

Efficacy of Short-Course vs Long-Course Antibiotic Therapy for Community-Acquired Pneumonia:A Systematic Review and Meta-Analysis

Region

Japan


Condition

Condition

Community-acquired pneumonia

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will conduct a systematic review and meta-analysis of the efficacy of short-term therapy (<= 7days) vs long-term therapy (>7 days) for community-acquired pneumonia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Prognosis, clinical efficacy, relapse of pneumonia, hospital days, adverse events, cost

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with community-acquired pneumonia aged 18 years or older.

Key exclusion criteria

Pediatric patients.

Target sample size



Research contact person

Name of lead principal investigator

1st name Shotaro
Middle name
Last name Ide

Organization

Nagasaki University Hospital

Division name

Infectious Diseases Experts Training Center

Zip code

8528501

Address

1-7-1, Sakamoto, Nagasaki-city, Nagasaki, Japan

TEL

095-819-7506

Email

str-ide@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Shotaro
Middle name
Last name Ide

Organization

Nagasaki University Hospital

Division name

Infectious Diseases Experts Training Center

Zip code

8528501

Address

1-7-1, Sakamoto, Nagasaki-city, Nagasaki, Japan

TEL

095-819-7506

Homepage URL


Email

str-ide@nagasaki-u.ac.jp


Sponsor or person

Institute

Japan Respiratory Society

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Respiratory Society

Address

8-28-3, Hongo, Bunkyo-ku, Tokyo, Japan

Tel

03-5805-3553

Email

info@jrs.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

長崎大学病院(長崎県)


Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 04 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.jrs.or.jp/publication/jrs_guidelines/20240319125656.html

Number of participants that the trial has enrolled

3077

Results

A total of 22 RCTs were analyzed. Short-term treatment showed no significant differences in mortality, cure rate, recurrence rate, or adverse event rate compared to standard treatment (>1 week). It reduced hospital stay by 0.85 days (not significant) and was reported to lower medical costs. The "Number of Participants" field reflects the number used in the mortality analysis.

Results date posted

2025 Year 01 Month 05 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2024 Year 04 Month 05 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 08 Month 31 Day

Date of IRB

2022 Year 08 Month 31 Day

Anticipated trial start date

2022 Year 08 Month 31 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A systematic search of the literature was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) statement. The Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE via PubMed, and medical journals were used as electronic databases. Other resources included the World Health Organization International Clinical Trials Platform Search Portal (ICTRP) and ClinicalTrials.gov. Review Manager 5.4 was used for meta-analysis. This systematic review was based on published literature and did not involve the collection or use of new data from human subjects. Therefore, it was not submitted for review by an Institutional Review Board (IRB). However, due to the requirements of the UMIN registration system, a placeholder date was entered in the "Date of IRB Approval" field.


Management information

Registered date

2023 Year 01 Month 04 Day

Last modified on

2025 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056899